Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Two mouse mutations cause similar hair loss despite different skin changes.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

DMAP scaffolds help tissue regeneration by activating B cells and humoral immunity.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

The project created a standardized system for classifying skin lesions in lab rats and mice.